Literature DB >> 15637348

Commercial rodent diets contain more sodium than rats need.

Wesley Martus1, Dennis Kim, Jeffrey L Garvin, William H Beierwaltes.   

Abstract

The dietary sodium requirements for rats have been a matter of debate. Our hypothesis was that normal commercial rodent chow contains sodium in excess of dietary needs and that this could have a significant impact on cardiovascular and renal physiology. To investigate dietary sodium requirements, 3-wk-old weanling Sprague-Dawley rats were fed a custom pelleted diet containing no sodium that was isocaloric to normal commercial rodent chow. These rats were provided with two drinking bottles; one contained water, and the other contained 0.5% NaCl. Thus they could choose and consume sodium as needed. Age-matched controls received normal pelleted Harlan Teklad 22/5 rodent diet (0.5% sodium content) and water ad libitum. Body weight and liquid intake were monitored over 7 wk until the rats were 10 wk old. At the end of the study, blood pressure was recorded. Weekly sodium intake in the experimental group was only 15% of that reported for rats fed normal rodent chow beginning in the first week postweaning. Growth was identical in the two groups (7.8 +/- 0.1 vs. 7.6 +/- 0.1 g/day), as was the total fluid volume intake. Blood pressure was significantly lower in the experimental rats compared with controls (96 +/- 4 vs. 122 +/- 4 mmHg, P < 0.05). These data suggest that, when given the choice, rats will consume significantly less sodium than provided in commercial chow, without any alteration in their growth rate. Rats fed standard commercial rodent chow may consume at least seven times more sodium than is necessary. This suggests commercial rodent diets may force excess sodium to accommodate caloric intake.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15637348     DOI: 10.1152/ajprenal.00310.2004

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  7 in total

Review 1.  Renal renin secretion as regulator of body fluid homeostasis.

Authors:  Mads Damkjær; Gustaf L Isaksson; Jane Stubbe; Boye L Jensen; Kasper Assersen; Peter Bie
Journal:  Pflugers Arch       Date:  2012-10-25       Impact factor: 3.657

2.  Reproductive parameters and oxidative stress status of male rats fed with low and high salt diet.

Authors:  Bolanle O Iranloye; Gabriel O Oludare; Ayodele O Morakinyo; Naomi A Esume; Lucy C Ekeh
Journal:  J Hum Reprod Sci       Date:  2013-10

3.  Maternal diet during gestation and lactation modifies the severity of salt-induced hypertension and renal injury in Dahl salt-sensitive rats.

Authors:  Aron M Geurts; David L Mattson; Pengyuan Liu; Erwin Cabacungan; Meredith M Skelton; Theresa M Kurth; Chun Yang; Bradley T Endres; Jason Klotz; Mingyu Liang; Allen W Cowley
Journal:  Hypertension       Date:  2014-12-01       Impact factor: 10.190

Review 4.  Thick Ascending Limb Sodium Transport in the Pathogenesis of Hypertension.

Authors:  Agustin Gonzalez-Vicente; Fara Saez; Casandra M Monzon; Jessica Asirwatham; Jeffrey L Garvin
Journal:  Physiol Rev       Date:  2019-01-01       Impact factor: 37.312

Review 5.  Brain mineralocorticoid receptors in cognition and cardiovascular homeostasis.

Authors:  Elise P Gomez-Sanchez
Journal:  Steroids       Date:  2014-12       Impact factor: 2.668

6.  Salt-Sensitive Hypertension, Renal Injury, and Renal Vasodysfunction Associated With Dahl Salt-Sensitive Rats Are Abolished in Consomic SS.BN1 Rats.

Authors:  Jacqueline C Potter; Shannon A Whiles; Conor B Miles; Jenna B Whiles; Mark A Mitchell; Brianna E Biederman; Febronia M Dawoud; Kevin F Breuel; Geoffrey A Williamson; Maria M Picken; Aaron J Polichnowski
Journal:  J Am Heart Assoc       Date:  2021-10-23       Impact factor: 5.501

7.  Super, red palm and palm oleins improve the blood pressure, heart size, aortic media thickness and lipid profile in spontaneously hypertensive rats.

Authors:  Chee-Meng Boon; Mei-Han Ng; Yuen-May Choo; Shiueh-Lian Mok
Journal:  PLoS One       Date:  2013-02-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.